A survey of health professionals’ views on acceptable gestational age and termination of pregnancy for fetal anomaly by Crowe L et al.
1 
 
A survey of Health Professionals’ views on acceptable gestational age and 
termination of pregnancy for fetal anomaly  
 
Lisa Crowe,1 Ruth H Graham,2 Stephen C Robson,3 Judith Rankin.1 
1Institute of Health & Society, Baddiley-Clark Building, Newcastle University, NE2 4AX.  
2 School of Geography, Politics and Sociology, 5th Floor Claremont Bridge Building, Newcastle 
University, NE1 7RU.  
3 Institute of Cellular Medicine, 3rd Floor William Leech Building, Newcastle University, NE2 
4HH.  
 
 
Corresponding Author:  
Lisa Crowe  
Institute of Health & Society, Baddiley-Clark Building, Newcastle University, NE2 4AX, UK. 
(+44) 0191 208 3812  
Lisa.Crowe@ncl.ac.uk 
 
 
 
 
 
 
 
 
 
2 
 
Abstract 
Termination of pregnancy for fetal anomaly is legal in the UK with no upper limit, if two 
doctors, in good faith, agree “there is a substantial risk that if the child were born it would suffer 
from such physical or mental abnormalities as to be seriously handicapped”. This is Clause E of 
the Human Fertlisation and Embryology Act. The most commonly sighted Clause is C, which 
states “the pregnancy has not exceeded its twenty-fourth week and that the continuance of the 
pregnancy would involve risk, greater than if the pregnancy were terminated, of injury to the 
physical or mental health of the pregnant woman”. This study aimed to investigate health 
professionals’ views on gestational age and acceptable termination of pregnancy for fetal 
anomaly (TOPFA).  
 
 
We undertook a questionnaire survey of UK health professionals working in fetal medicine, 
obstetrics and gynaecology and neonatology. A study pack consisting of a self-completion 
questionnaire, an invitation letter, participant information sheet, and a stamped addressed return 
envelope, were sent to health professionals. We used four fetal anomalies as case study examples 
in the questionnaire: isolated cleft lip, hypoplastic left heart, spina bifida and trisomy 21. These 
anomalies were chosen as they differed in terms of the type of anomaly, the type of impairment, 
and the perceived severity.  
 
Forty-one study packs were returned. For anomalies deemed less serious, later gestational ages 
were an important consideration when deciding acceptable TOPFA. Long term prognosis was 
considered an important factor in deciding whether a TOPFA was acceptable alongside 
gestational age. Clause C of the current UK legislation, which allows a legal termination prior to 
24 weeks gestational age if continuing with the pregnancy would impact the mental health of the 
mother, was deemed a reasonable option for termination when parents are requesting a TOPFA. 
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For each case study example, health professionals responded that TOPFA at ‘25 weeks and over’ 
was acceptable (cleft lip n=1; hypoplastic left heart n=19; spina bifida n=13 and Trisomy 21 
n=10). Professionals also distinguished between their personal and professional views. 
 
These findings offer new insight into how gestational age considerations influence professionals’ 
conceptualisation of acceptable TOPFA.  
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Main text 
In England and Wales, the Abortion Act(1) and the Human Fertilisation and Embryology Act 
(HFEA)(2) allow termination of pregnancy for fetal anomaly (TOPFA) at any gestation. Clause 
E of the HFEA states that a TOPFA is legal if two doctors, in good faith, agree “there is a 
substantial risk that if the child were born it would suffer from such physical or mental 
abnormalities as to be seriously handicapped”(2). There is no list that defines which fetal 
anomalies meet these criteria. However some TOPFA is performed under Clause C of the 
HFEA which states that: ‘the pregnancy has not exceeded its twenty-fourth week and that the 
continuance of the pregnancy would involve risk, greater than if the pregnancy were terminated, 
of injury to the physical or mental health of the pregnant woman.’  In this circumstance it is 
presumed the doctors do not believe the anomaly is sufficiently serious to fulfil the criteria for 
Clause E. 
 
The Royal College of Obstetrics and Gynaecology(3, 4) (RCOG) has produced guidelines to 
support professionals when making such decisions. The National Health Service (NHS) Fetal 
Anomaly Screening Programme (FASP) defines a fetal anomaly as an abnormality which “may 
indicate the baby might die shortly after birth, conditions that may benefit from treatment before 
birth, to plan delivery in an appropriate hospital/Centre and/or to optimize treatment after the 
baby is born”(5). All routine antenatal ultrasound screening for fetal anomalies is recommended 
between 18+0 and 20+6 weeks of pregnancy, and is offered to all pregnant women through the 
NHS FASP programme.(5)  
 
Fetal viability is defined as the point where the fetus can survive independently of the pregnant 
woman. Viability is considered to be 24 weeks’ gestational age in the UK.(6) The RCOG define a 
‘threshold of viability’ as 23+0 weeks to 24+6 weeks’ gestational age.(7)  These guidelines state an 
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international consensus that “at 22 weeks of gestation there is no hope of survival, and that up to 
22+6 weeks is considered to be the cut-off of human viability and for week 25+0 onwards there is 
also a general agreement that active management should be offered”.(7) While survival following 
premature birth has increased, morbidity has not,(7) and preterm labour, in particular prior to 26 
weeks’ gestation, continues to be a primary cause of neonatal mortality and morbidity.(8) Active 
intervention after the birth of extremely premature infants has been shown to vary across 
Europe.(8) This was particularly the case for births prior to 25 weeks’ gestation.(8) While viability 
is considered to be around 24 weeks’ gestational age, the Clauses in the UK HFEA1 do not 
specify viability, only gestational age. Viability, however, was a consideration setting the limits in 
the TOP legislation.(9) Fetal viability has also been used in further debates in 2008 around 
reducing the upper limit to 22 or 20 weeks, although no changes to legislation occurred.(10) 
 
In 2016, there were 180,794 terminations conducted under Clause C representing 97% of the 
total.(11) That same year, there were reported to be 3,208 terminations conducted under Clause 
E; this represents 2% of the total number of terminations.(11) Research has found that medical 
professionals raise concerns about the difficulty of defining terms such as ‘substantial’ and 
‘serious’.(12-14) This is coupled with variations in views on impairment and disability among 
parents and medical providers,(8) which may both impact perceptions of ‘substantial’ and 
‘serious’. Using Clause C, after a diagnosis of fetal anomaly, is an option available to medical 
professionals if the pregnancy is sub 24 weeks’ gestation. Using Clause C in the provision of a 
termination, removes the fetal anomaly as the primary reason for the termination.(15) This 
allows medical professionals to authorise a termination request by parents, that they may not feel 
falls into Clause E, or where they feel additional moral arguments are legitimate to the decision 
making process.(15) So while the legislation offers the legal framework for TOPFA, this does 
                                                 
1 Abortion in Northern Ireland remains governed by the Offenses Against the Persons Act, 
1861.   
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not mean that all TOP with an affected fetus is captured in the data for terminations under 
Clause E.  
 
This study aimed to investigate health professionals’ views on gestational age and acceptable 
TOPFA using four fetal anomalies as case study examples.  
 
Sample Characteristics 
The sample consisted of medical professionals at consultant level (n=41/114, response rate 
36%) from a range of specialties; obstetrics, gynaecology, neonatology, paediatrics and fetal 
medicine in four NHS sites in the North East of England. Each of the four NHS sites had a 
primary investigator affiliated to this study. These primary investigators acted as a gatekeeper to 
the medical professional community, distributing the research packs to the relevant professionals 
at that particular research site.  
 
 
Fetal anomaly subtypes used in the case studies 
Four fetal anomaly subtypes were selected for inclusion in the study. The cases were; isolated 
cleft lip, hypoplastic left heart (HLH), spina bifida and Trisomy 21. These anomalies were 
selected based on the type of anomaly (structural or chromosomal), the type of impairment 
(physical or cognitive), and the perceived severity. Within the case studies, the prognoses ranged 
from lethal without medical intervention (HLH) to a perceived normal life experience following 
intervention (isolated cleft lip). The range of anomaly characteristics included allowed us to 
explore the impact of such variations in professionals’ understandings of how gestational age 
impacts on their decisions about TOPFA. 
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Methods 
This research forms part of a larger mixed methods study investigating TOP for non-lethal fetal 
anomaly.(16) A study pack consisting of a self-completion questionnaire, which included fixed 
response and open ended questions, an invitation letter, participant information sheet, and a 
stamped addressed return envelope, were sent to medical professionals. The questionnaire was 
split into 4 sections: the first asked some general questions about TOP; section 2 were case study 
specific questions; section 3 some demographic information; and section 4 was an invitation to 
interview. This paper is focusing on data gained from section 2, the case study specific questions, 
which asked questions specific to gestational age. In the questionnaire, participants were asked a 
specific question about the gestational age at which they thought TOPFA became acceptable for 
each of the four case study examples. Respondents were provided with six categories of 
gestational age to choose from, with space to comment on their response. These categories were; 
never; 25 or more weeks; 22-24 weeks; 19-21 weeks; 13-18 weeks; less than 12 weeks. Illustrative 
quotes are presented with the results. Eight health professionals did not select a specific 
gestational age category but used the ‘comments’ section to provide an answer (n=7) in which 
gestational age was given. 
 
 
Results 
A total of 114 study packs were sent out and 41 were returned (response rate 36%).  There were 
22 (53.6%) female and 19 (46.3%) male health professionals in the study sample. Additional 
information on the sample characteristics cannot be provided due to confidentiality and the 
sensitivity of the research topic. The gestational age categories at which respondents considered 
TOPFA was acceptable for each anomaly case study are presented in Figure 1. 
 
Cleft lip  
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Almost half of the respondents (20; 48.8%) responded that TOPFA for cleft lip was not 
acceptable at any gestational age. Health professionals provided some insight into their choices 
which included; personal opinion statements, some explanation regarding treatment and 
distinguishing between personal and professional opinions. 
 
Personally never, professionally <20 weeks. 
 
‘I can’t even imagine why someone would terminate a potentially healthy baby for a cleft lip and it 
certainly shouldn’t even be offered as an option.  
 
Cleft lip is very treatable, so I see no reason for TOP. 
 
However, seven (17.1%) respondents considered that TOPFA was acceptable at 22-24 weeks of 
gestation (Fig. 1). Rather than the anomaly being the primary justification of TOPFA, health 
professionals appear to adopt Clause C of the legislation. 
 
Never: because you TOP for the maternal mental health Clause C not for Clause E. 
 
… both professionally and personally I wouldn’t ‘recommend/support’ a TOP request for isolated cleft 
lip. However, if after counselling by appropriate professionals, the patient was still very distressed 
requesting TOP, I would proceed but under Clause C.  
 
One health professional commented on a personal experience of performing a TOPFA for cleft 
lip;  
I have been coerced into TOP (mid trimester ~ 20/40) for isolated cleft lip many years ago. I regret it. 
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Hypoplastic left heart 
Nineteen (43%) respondents said they would support TOPFA at any gestational age (Fig. 1). The 
open responses suggested that this choice was based on health professionals’ knowledge 
regarding the difficulty of diagnosing HLH prenatally.   
 
Difficult diagnosis before 20 week anomaly ultrasound. 
 
I don’t think definitive diagnosis made locally prior to 19 weeks gestation. 
 
The perceived severity of the condition was also discussed by respondents, who were thus 
employing the ‘no upper limit’ aspect of Clause E.    
 
…at any stage, when the diagnosis is certain.  
 
HLH is a grim condition therefore TOP I believe would be acceptable. Children with HLH have a 
great deal of suffering. 
 
I feel personally uncomfortable about late terminations and would accept if a serious medical condition e.g. 
HLH.  
 
Respondents also suggested that alternatives to TOPFA should be considered depending on the 
severity of the prognosis, and the availability of treatment.  
 
If prognosis is not bad, surgical correction often first should be offered.  
 
HLH, though may require several surgeries, is treatable. 
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Differences between a personal and professional opinions were also noted.  
 
Not an easy question, personally <24 weeks, professionally >31 weeks. 
 
Spina bifida 
The majority of respondents selected two gestational age categories as being acceptable for 
TOPFA for spina bifida: 22-24 weeks (14; 34.1%) and 25 weeks and over (13; 31.7%). Health 
professionals indicated that the severity of the anomaly (in terms of type and extent of the 
defect) was the basis for the differences in views around acceptability of TOPFA at different 
gestational ages.  
 
Before viability, if a minor defect. 
 
Depends upon level of lesion. 
 
Again, dependent on the degree of spina bifida and progression of associated issues (such as 
hydrocephalus), I would deem this to be a ‘serious’ anomaly. Would seek tertiary opinion > 24 weeks. 
 
It should also depend on what kind of spina bifida. Some are asymptomatic and hence no need for TOP 
because they would live normal life. 
 
Respondents also considered later gestational age when discussing the severity and thus 
acceptability of TOPFA for spina bifida.  
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I feel personally uncomfortable about late terminations unless serious medical condition spina bifida as a 
diagnosis covers a range of severities. 
 
I doubt isolated spina bifida would be diagnosed prior to 15 weeks locally. I feel anxious about saying 
that TOP for isolated spina bifida beyond 30 weeks is acceptable especially if diagnosis made at 20 
weeks. 
 
Late diagnosis and ‘likely’ (up arrow) handicap could persuade me that later TOP would be acceptable.  
 
As with isolated cleft lip, one respondent distinguished between their personal and professional 
opinions.  
 
Same as for HLH - Not an easy question, personally <24 weeks, professionally >31 weeks.  
 
Trisomy 21 
Sixteen (39%) and 10 (24.4%) respondents selected ‘22-24 weeks’ and ‘25 weeks and over’ 
respectively. The responses to open questions indicated that views were influenced by the 
presence or absence of other structural anomalies.  
 
TOP only if multiple defects associated with the chromosomal abnormality.  
 
This is presuming that diagnosis made before 25 weeks and that the fetus does not have any known 
structural abnormality (e.g. AVSD etc).  
 
Depends when diagnosed, but more difficult to justify in ‘uncomplicated’ cases > 24 weeks.  
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  Would ask for tertiary opinion. 
 
Any gestation if other anomalies e.g. cardiac abnormalities.  
 
Respondents commonly noted that they were personally against TOP for Trisomy 21 but could 
appreciate the request in a professional capacity.  
 
Feel personally uncomfortable unless serious medical problems. Should terminate Downs syndrome earlier 
but justifying of additional problems later may affect need for late termination.  
Professional opinion. Not personal.  
 
I wouldn’t agree personally but professionally I understand why, for a lot of parents, continuing with a 
Downs pregnancy is not right for them. 
 
I would not recommend this TOP for Downs syndrome but if it in parental choice I will understand and 
accept this. 
 
I personally feel TOP for Downs is never acceptable. However if current ethics allows TOP then it must 
be done <21/40.   
 
 
Discussion 
This study investigated health professionals’ views on the influence of gestational age on the 
acceptability of TOPFA using four different fetal anomalies as case study examples. Our findings 
suggest a number of factors influence health professionals’ decision-making about gestational age 
and acceptable TOPFA. These include: the prognosis of an anomaly; the option of invoking 
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Clause C of the HFEA; and differentiating between personal and professional opinions. 
Professionals have the option of offering a TOP under Clause C if the pregnancy is sub-24 
weeks, and they do not feel the anomaly fulfilled the criteria for Clause E. Given the likelihood 
of health professionals being able to separate their personal beliefs from their professional role is 
limited,(17) it is of vital importance to consider these issues. A range of views both within and 
between case studies, and perspectives of health professionals who are working in this field, were 
provided. This range is of particular interest considering that the four case studies covered both 
an anomaly considered to be minor and one that is more serious in terms of functionality. 
 
Gestational age is often considered in conjunction with the long term prognosis of the fetal 
anomaly. For example, tension emerged when discussing spina bifida and Trisomy 21 and 
acceptable TOPFA. Acceptable TOPFA was negotiated at later gestational ages if there was the 
presence of additional anomalies which may influence the long term prognosis of the affected 
fetus. Clause C was revealed to be an option health professionals adopt after a diagnosis of fetal 
anomaly. This was in instances where health professionals did not agree that the fetal anomaly in 
question was serious enough to justify a TOPFA under Clause E of the HFEA. The acceptability 
of terminations around 22-24 weeks, and the use of Clause C, may suggest that the age of 
viability is being adopted as an indicator of acceptable TOP. However, only one health 
professional explicitly referred to viability in their decision making; this was in reference to spina 
bifida. While the option of Clause C may be preferred by health professionals who may have 
ethical concerns about the reason for the termination request, there is no research into parents’ 
feelings in this distinction. This is of particular interest as parents terminating a wanted child do 
not wish to be likened to those who are terminating an unwanted pregnancy(18). A further 
important consideration is that professional views have the potential of resulting in no access to 
termination services after 24 weeks, after the point at which Clause C can be used. 
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Health professionals indicated that they considered TOPFA was acceptable at less than 19 weeks 
gestational age. Unlike Trisomy 21, where screening is offered at 11-14 weeks in the UK, 
screening for structural fetal anomalies with ultrasound  is not offered until 18+0 and 20+6 weeks 
pregnancy.(4) Thus, in principle, TOP for structural anomalies is not a consideration prior to 18 
weeks. This did not, however, stop professionals selecting earlier gestation categories. While the 
structural anomalies chosen can be reliably diagnosed after 12 weeks (19-23), responses may be 
suggestive of a more idealised model of care or what health professionals think may be 
achievable diagnoses if accessing care at specialised Centre’s in a timely manner. This is of 
importance as gestational age appears to influence decisions about acceptable TOPFA. This may 
subsequently influence attitudes towards TOPFA requests and the counselling parents receive 
after a diagnosis.   
 
The data also reveal other factors that inform the decision making process. Some differences 
between personal and professional opinions were reported, with health professionals often being 
more accepting of later TOPFA in a professional capacity than in their personal views. However, 
some health professionals reported that they do not differentiate between TOP at any gestational 
age. This may explain why the ‘25 weeks and over’ category was an option selected for all four 
case studies in at least some instances. Other research has found the personal views of health 
professionals may influence counselling after a diagnosis of fetal anomalies; for example, 
religious affiliation.(24) This insight is important given the high sensitivity of late TOP and the 
potential impact of professional views on the patient. These issues are further intensified when 
considering that the wordings of the relevant legislation, both in the UK and other countries that 
provide TOPFA, are open to interpretation,(25) thus potentially creating subjective decision 
making. Health professionals in the field are in a unique position where they may be very 
influential to patients’ decision making during a very vulnerable time. For example, research has 
found parents feeling counselled towards TOPFA after a diagnosis of fetal anomaly.(26, 27) 
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Thus, it is essential that the potential impact of professionals’ personal views on issues 
surrounding gestational age to be considered in discussions of policy making and 
implementation. This is not to suggest that professionals would be acting with any intentionality, 
rather that personal views can potentially impact on professional activity in an unconscious 
manner.(28) 
 
Gestational age has been found in other studies to be an influential factor in issues surrounding 
TOPFA. Gestational age restrictions have been found to be imposed by healthcare professionals 
on TOPFA for ‘commonly lethal’ anomalies (for example, Trisomy 13 and 18).(29) Other 
research found difficulties accessing a late TOPFA for a lethal anomaly after 24 weeks in the 
US.(30) The ‘age of fetus’ has also been found to be influential when deciding whether to 
undertake a surgical TOP.(31) Relating specifically to fetal anomaly, research has found differing 
levels of objection to TOP depending on the reason behind the request (for sex selection, 82% 
of the sample of obstetricians and gynaecologists, objected to TOP, whereas for 
cardiopulmonary disease, 16% objected).(32) For UK medical students, willingness to sign the 
paperwork to authorise TOP decreased with late pregnancy compared to early pregnancy.(33) 
Increasing gestational age has also been revealed as an indicator of reduced willingness to 
participate in both TOP and TOPFA services.(34) Harris et al. 2011, however noted a power 
imbalance in these decision making processes given it is the health professionals who are 
determining whether a reason is good enough to justify TOP,(32) highlighting the importance of 
understanding health professionals’ views as they can be seen to be a gatekeeper to services. It 
should be noted that a number of these studies have been undertaken in the USA, where the 
debates and legislation on both TOP and TOPFA procedures differ to that of England and 
Wales, but the fact that these debates extend beyond the UK suggests that these issues are of 
broader relevance. 
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The study has several strengths. While the sample is not extensive, we have found important data 
pertaining to gestational age and acceptable TOPFA. We have also included different health 
professional groups, and a set of four case study examples that encompass a range of anomaly 
characteristics. The data also demonstrate some professionals’ differences between their personal 
and professional opinions. This may suggest professionals’ ability and willingness to work within 
a professional paradigm despite it being in conflict with their own personal opinions. 
 
However, the study also has limitations. There is a high number of non-responses. While it is 
important not to detract from the valuable insights provided by the 41 respondents, we must 
acknowledge that if the response rate had been higher, the results may have been different. The 
data were derived from a survey with fixed choice answers and space for additional comments. 
This may have resulted in ambiguities if respondents were not able to fully express their reasons. 
Our question offered no definition of severity of the fetal anomaly which also may have 
impacted responses. It is important to note that there is a considerable range of disability, with 
an uncertain prognosis within some of these case studies. The question this paper poses to 
professionals did not provide respondents with opportunities to comment in detail on the 
complexity of the characteristics case study examples.   
 
Our study has specifically asked health professionals to select a gestational age range by anomaly 
subtype. The findings therefore add to existing knowledge on provision of TOPFA by offering 
an insight into the limits in provision to which professionals will go to under Clause E. We also 
provide an insight into some of the reasoning behind the boundaries identified by professionals, 
often demonstrating their differing personal and professional limits to acceptability in TOPFA 
provision. In our small sample, the category ‘25 weeks and over’ remained a legitimate 
termination option for some professionals in all the case study examples provided. This suggests 
a range of perspectives continue to work within the health care setting, and additional research is 
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needed to understand and further analyse these competing views. Only then can we assess the 
long term impact this may have on patient choice.  
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 Figure 1: Health professionals’ views of the acceptable gestational limit for termination of pregnancy for fetal anomaly. 
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